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Abstract 
Introduction: Previous studies have shown that there is a probability of seizure even with therapeutic doses of 
tramadol. Yet, no accurate data exist regarding this problem in Iran. Therefore, the present study aimed to evaluate 
the prevalence of tramadol consumption in patients with first seizure referred to the emergency department (ED). 
Methods: In the present retrospective one-year cross-sectional study, all patients who were referred to the ED of 
Poursina Hospital, Rasht, Iran, with the complaint of first seizure were evaluated. Demographic data and data re-
garding history of tramadol consumption, duration, total dose, last dose, and time passed from the last dose of 
consumption were recorded and analyzed regarding the study questions using SPSS 20. Results: 383 (68.9%) out 
of the 556 patients referred to the ED, were experiencing their first seizure (mean age 26.43 ± 6.48 years; 70.5% 
male). 84 (21.9%) patients had recently used tramadol. History of seizure in the family of tramadol consumers was 
significantly lower (3.6% compared to 11%; p = 0.036). Mean total tramadol consumption dose in the last 24 hours 
was 140.17 ± 73.53 mg (range: 50-300 mg). Duration of tramadol consumption was less than 10 days in 84.5% (df: 
2; χ2 = 96.1; p < 0.001). In addition, 62 (73.8%) patients had seizure within 6 hours of consumption (df: 3; χ2 = 29.5; 
p < 0.001). Conclusion: Results of the present study showed that 21.9% of the patients with first seizure had a 
history of tramadol consumption. Seizure following tramadol consumption is more prevalent in the initial 10 days 
and within 6 hours of consumption. In addition, it seems that lower doses of tramadol may also induce seizure. 
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Introduction: 
ramadol is an opioid used for treating moderate to 
severe pain. It has been legally used for pain man-
agement since 1980 in some countries, and has 
been approved by food and drug administration of Iran 
since 2003. This drug is addictive and may be abused by 
the youth. Nausea, vomiting, central nervous system de-
pression, tachycardia, cardiorespiratory arrest, and sei-
zure are among the side effects of tramadol poisoning. 
However, there are reports that indicate the probability 
of seizure induction even with therapeutic doses of this 
drug (1-5). Tramadol abuse is increasing in Iran, (2, 6) 
and seizure is possible among abusers. Therefore, the 
present study aimed to evaluate the prevalence of tra-
madol abuse in patients with first seizure, who were re-
ferred to the emergency department (ED). 
Methods: 
In the present retrospective cross-sectional one-year 
study, all first seizure patients referred to the ED of 
Poursina Hospital, Rasht, Iran, during 2012 were evalu-
ated. For each patient, data regarding age, sex, history of 
seizure in family, recent history of tramadol consump-
tion, duration (days), total dose, last dose, and time 
passed from the last dose of consumption were recorded 
using a checklist. Data were then analyzed using SPSS 
20.0. Quantitative data were reported as mean ± SD and 
qualitative ones as frequency and percentage. The 
groups with and without recent tramadol consumption 
were compared using independent t-test for quantitative 
variables and chi square or Fisher’s exact test for quali-
tative ones. In addition, multinomial logistic regression 
test was used to evaluate distribution of the patients in 
groups regarding age, sex, duration of consumption, con-
sumed dose in the last 24 hours, and time passed from 
the last dose of tramadol consumption. In all analyses, p 
< 0.05 was considered as significance level. This study 
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was approved by the Ethics Committee of Guilan Univer-
sity of Medical Sciences. The researchers adhered to the 
principles of Helsinki declaration.  
Results: 
383 (68.9%) out of the 556 patients who were referred 
to the ED with chief complaint of seizure throughout 
the course of the study, were experiencing their first 
seizure. Mean age of first seizure patients was 26.43 ± 
6.48 years (range: 16-55 years; 70.5% male). 84 
(21.9%) patients out of the 383 first seizures had re-
cent history of tramadol consumption. 69 (82.1%) of 
tramadol consumers and 201 (67.2%) of other patients 
were male (p = 0.005). 48.8% of the tramadol consum-
ing patients and 59.9% of other patients were 20-30 
years old (p = 0.016). History of seizure in the family of 
tramadol consumers was significantly lower (3.6% 
compared to 11%; p = 0.036). Table 1 shows baseline 
characteristics of the tramadol consumers. Mean total 
tramadol consumption dose in the last 24 hours was 
140.17 ± 73.53 mg (range: 50-300 mg). Duration of con-
sumption was less than 10 days in 84.5% of the pa-
tients, 11-20 days in 10.7%, and more than 20 days in 
4.8%. Incidence of seizure following ingestion was 
higher in patients who had recently started consump-
tion (df: 2; χ2 = 96.1; p < 0.001). Yet, no correlation was 
detected between tramadol dosage and seizure inci-
dence (df: 3; χ2 = 1.2; p = 0.1). Seizure had occurred 
within 6 hours of consumption in 62 (73.8%) patients 
(df: 3; χ2 = 29.5; p < 0.001). 
Discussion: 
Findings of the present study showed that 68.9% of the 
patients referred to Poursina Hospital, Rasht, Iran, were 
experiencing their first seizure, 21.9% of which had re-
cent history of tramadol consumption. Seizure following 
tramadol consumption was more prevalent in the initial 
10 days and within 6 hours of consumption. Previous 
studies show that about 86% of neurologic side effects 
manifest within 6 hours of consumption (7, 8). The pre-
sent study showed that 73.8% of seizures due to tra-
madol consumption also happened in this time. Based on 
the existing standards, to prevent side effects such as sei-
zure, daily dose of tramadol should not exceed 400 mg 
(1, 2, 9). In this cross-section, mean total tramadol con-
sumption dose in 24 hours was 140.17 ± 73.53 mg. In a 
study by Shadnia et al. (2), this dose was 1650 mg while, 
in a study by Pedramfar et al. (5), total dose in the 12 
hours pre-seizure was 363.2 ± 303.1 mg (50 -1500). 
Mean consumption dose in the participants of this study 
was significantly lower than the mentioned studies. This 
may be due to the patients not revealing their real con-
sumption dose, genetic differences in the studied popu-
lations, different pharmaceutical companies making the 
drugs and other unknown reasons. Therefore, we should 
note that tramadol might also be able to induce seizure 
in lower doses. One of the limitations of this study was 
being retrospective, which led to limited access to some 
 
Table 1: Baseline characteristics of tramadol consuming patients 
Characteristics Number (%) P value 
Sex     
Male  69 (82.1) ref 
Female  15 (17.9) <0.001 
Age (Year)   
< 20  19 (22.7) 0.006 
20-30 41 (48.8) ref 
31-40 18 (21.4) 0.004 
> 40 6 (7.1) <0.001 
Consumption duration (Day)   
< 10  71 (84.5) ref 
11-20  9 (10.7) <0.001 
> 20  4 (4.8) <0.001 
Dose in the last 24 hours (mg)   
50  16 (19.0) ref 
50-100 27 (32.1) 0.1 
100-200 29 (34.5) 0.06 
> 200 12 (14.3) 0.45 
Time passed since the last dose (Hour)   
< 3 hours 32 (38.1) ref 
3-6 hours 30 (35.7) 0.8 
6-12 hours 18 (21.4) 0.049 
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of the required data. Moreover, serum tramadol level 
was not evaluated and therefore its correlation with sei-
zure incidence could not be determined. 
Conclusion: 
Results of the present study showed that 21.9% of the 
patients with first seizure had a history of tramadol con-
sumption. Seizure following tramadol consumption is 
more prevalent in the initial 10 days and within 6 hours 
of consumption. Although the maximum recommended 
therapeutic dose of tramadol is 400 mg/day, mean con-
sumption dose among the participants of this study was 
140.17 ± 53.73 mg. Therefore, we might be able to con-
clude that lower doses of tramadol may also induce sei-
zure. 
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